On Friday, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) reported second-quarter adjusted earnings of $12.89 per share, up 12% ...

The Washington Post reported on Friday that state Medicaid programs and Medicare Part D insurance plans will be able to ...

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

Investor sentiment soured after July’s nonfarm payrolls came in at just 73,000, missing estimates by a wide margin. Revisions ...